Exploring Precision Medicine & Biotech in Boston (May 2016)

Focusing on Precision Medicine and Biotechnology, INTO Global Business Communications led a high-level business delegation of executives and investors from prominent Chinese Medtech companies, including Health 100, Zhongsheng Pharma (SZSE:002317), Guizhou Yibai Pharmaceutical (SHSE:600594), Guanhao Biotech (SZSE:300238), and Greenwoods Asset Management, to Boston in May 2016. The visit facilitated in-depth discussions with key industry players such as Foundation Medicine, Dimension Therapeutics, Voyager Therapeutics, Jounce Therapeutics, Moderna Therapeutics, Yumanity Therapeutics, and Third Rock Venture.

Meeting with Foundation Medicine

Meeting with Dimension Therapeutics

Meeting with Voyager Therapeutics

Meeting with Jounce Therapeutics

Meeting with Moderna Therapeutics

Meeting with Yumanity Therapeutics

Meeting with Third Rock Venture

中文链接: http://www.intoer.com/archives/1287.html